PATENT CLAIM ANALYSIS

Application Number: 15779419
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are compositions, method and uses for modulating MCT4 activity or for the treatment of cancer. The compositions comprise antisense oligonucleotides (ASO) for administration to a cancer cell, wherein the cancer cell may be characterized by elevated expression of MCT4. The cancer may be selected from one or more of: prostate cancer; renal cell carcinoma; breast cancer; cervical cancer; liver cancer; bladder cancer; and small cell lung cancer pr. The prostate cancer may be castration-resistant prostate cancer (CRPC).

Claim (Index 27):
The ASO of any one of  claims 19 - 26  for use in the treatment of cancer.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 93.0
- Lexical Diversity: 1.77778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15211857', '12578471', '14247799', '11470331', '13546799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8247705890290401
- 35 USC 102 Novelty (BERT): 0.5583443414803554
- Combined Prediction Score: 0.7981279642741717
- Mean Citation Score: 393.812492
- Max Citation Score: 514.1102
- Similarity Product: 285.92175407443045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test